Holbrook Kerr
SVP, Chief Commercial Officer
Holbrook Kerr has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2025.
On the most recent filing, Holbrook Kerr is listed as SVP, Chief Commercial Officer at AVANOS MEDICAL, INC. Inside the rolling window, Holbrook Kerr reported no open-market purchases and 1 open-market sale totaling $165K in AVNS.
Companies traded
Other insiders at AVNS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$165K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Holbrook Kerr made?
Holbrook Kerr has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2025.
Which companies does Holbrook Kerr trade?
Holbrook Kerr has filed SEC Form 4 disclosures for 1 company, including AVNS.
When was Holbrook Kerr's most recent SEC Form 4 filing?
Holbrook Kerr's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2025.
What is Holbrook Kerr's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Holbrook Kerr is listed as SVP, Chief Commercial Officer.
What is Holbrook Kerr's total buy and sell value in the current window?
Inside the rolling retention window, Holbrook Kerr bought $0 and sold $165K based on SEC Form 4 filings.
What was Holbrook Kerr's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 AVNS shares on 2025-11-18, worth $165K, per SEC Form 4 filings.